Literature DB >> 11954827

Kupffer cells protect liver from ischemia-reperfusion injury by an inducible nitric oxide synthase-dependent mechanism.

Ching-Mei Hsu1, Jyh-Seng Wang, Chao-Hsin Liu, Lee-Wei Chen.   

Abstract

The aim of this study was to investigate the role of nitric oxide (NO) in rat hepatic ischemia-reperfusion (I/R) injury. Animals were divided into four groups: Group I, control; Group II, gadolinium chloride (GdCl3), a Kupffer cell depleting agent, pretreated; Group III, S-methylisothiourea (SMT), a potent inducible NO synthase (iNOS) inhibitor, pretreated; Group IV, pretreated with SMT, then treated with S-Nitroso-N-acetylpenicillamine (SNAP), a NO donor, after ischemia. Sprague-Dawley rats underwent left lateral and median lobe ischemia for 60 min and reperfusion for 120 min. The left lateral and median lobes were used as ischemic lobes, and the right lateral lobe in the same rat was used as a control lobe. The total NOS (tNOS), iNOS, constitutive NOS (cNOS) activity, and liver protein were determined. The liver tissue malonaldehyde (MDA) level was measured as an index of lipid peroxidation. Liver histology was also examined. The liver tNOS activity in ischemic lobes of Group I, II, III, and IV was increased by 214%, 86%, 61%, and 45%, respectively. The increase in tNOS activity is mainly due to the induction of iNOS activity in the ischemic lobes of rat liver. GdCl3 significantly decreased the tNOS by 66% in the ischemic lobes. GdCl3 significantly increased MDA by 39% in the ischemic lobes. SMT significantly decreased tNOS and iNOS activity by 66% and 85% in ischemic lobes. SMT increased MDA by 67% in the ischemic lobes. SMT + SNAP treatment increased iNOS activity by 117% in the ischemic lobes in comparison with the ischemic lobes of the SMT group. SMT + SNAP treatment decreased MDA by 39% in the ischemic lobes. SMT + SNAP treatment also decreased the sinusoidal congestion and spotty necrosis of hepatocytes in the ischemic lobes. iNOS immunostaining showed an obvious increase in sinusodial area of the ischemic lobes where most Kupffer cells were interspersed. In conclusion, in this model of liver I/R injury, I/R increased the activity of tNOS and iNOS, but not the cNOS activity. Kupffer cells might be the major source of the induction of iNOS activity. The iNOS specific inhibitor SMT increased the lipid peroxidation and the tissue damage in hepatic I/R injury. On the contrary, the NO donor SNAP increased the activity of iNOS and decreased the hepatic injury in this study. Kupffer cells could protect liver from I/R injury by an iNOS-dependent mechanism, thus NO production has a beneficial role in hepatic IR injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11954827     DOI: 10.1097/00024382-200204000-00007

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  17 in total

Review 1.  Mechanisms of hepatic ischemia-reperfusion injury and protective effects of nitric oxide.

Authors:  Lian-Yue Guan; Pei-Yao Fu; Pei-Dong Li; Zhuo-Nan Li; Hong-Yu Liu; Min-Gang Xin; Wei Li
Journal:  World J Gastrointest Surg       Date:  2014-07-27

Review 2.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 3.  Role of Kupffer cells in the pathogenesis of liver disease.

Authors:  George Kolios; Vassilis Valatas; Elias Kouroumalis
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

4.  Inhibition of inducible nitric oxide synthase prevents hepatic, but not pulmonary, injury following ischemia-reperfusion of rat liver.

Authors:  Yuji Takamatsu; Kazuo Shimada; Koji Yamaguchi; Syoji Kuroki; Kazuo Chijiiwa; Masao Tanaka
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

5.  Carcinoembryonic antigen promotes tumor cell survival in liver through an IL-10-dependent pathway.

Authors:  J Milburn Jessup; R Samara; P Battle; L M Laguinge
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

6.  Pathomorphological study on location and distribution of Kupffer cells in hepatocellular carcinoma.

Authors:  Kai Liu; Xu He; Xue-Zhong Lei; Lian-San Zhao; Hong Tang; Li Liu; Bing-Jun Lei
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.

Authors:  Shujun Jiang; Zhen Shi; Changyong Li; Chunlei Ma; Xianyong Bai; Chaoyun Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

8.  Nitric oxide and MCP-1 regulation in LPS activated rat Kupffer cells.

Authors:  George Kolios; Vassilis Valatas; Pinelopi Manousou; Costas Xidakis; George Notas; Elias Kouroumalis
Journal:  Mol Cell Biochem       Date:  2008-07-16       Impact factor: 3.396

Review 9.  Melatonin role preventing steatohepatitis and improving liver transplantation results.

Authors:  Eduardo Esteban-Zubero; Francisco Agustín García-Gil; Laura López-Pingarrón; Moisés Alejandro Alatorre-Jiménez; José Manuel Ramírez; Dun-Xian Tan; José Joaquín García; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

10.  Influence of Kupffer cells on hepatic signal transduction as demonstrated by second messengers and nuclear transcription factors.

Authors:  Hong Ding; Jie-An Huang; Jing Tong; Xin Yu; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.